These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 12324552)

  • 1. Warfarin, aspirin, or both after myocardial infarction.
    Hurlen M; Abdelnoor M; Smith P; Erikssen J; Arnesen H
    N Engl J Med; 2002 Sep; 347(13):969-74. PubMed ID: 12324552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
    Gulløv AL; Koefoed BG; Petersen P
    Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study.
    Fiore LD; Ezekowitz MD; Brophy MT; Lu D; Sacco J; Peduzzi P;
    Circulation; 2002 Feb; 105(5):557-63. PubMed ID: 11827919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.
    Leon MB; Baim DS; Popma JJ; Gordon PC; Cutlip DE; Ho KK; Giambartolomei A; Diver DJ; Lasorda DM; Williams DO; Pocock SJ; Kuntz RE
    N Engl J Med; 1998 Dec; 339(23):1665-71. PubMed ID: 9834303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin and aspirin give more benefit than aspirin alone but also more bleeding after myocardial infarction.
    Doggrell SA
    Expert Opin Pharmacother; 2003 Apr; 4(4):587-90. PubMed ID: 12667121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.
    Cleland JG; Findlay I; Jafri S; Sutton G; Falk R; Bulpitt C; Prentice C; Ford I; Trainer A; Poole-Wilson PA
    Am Heart J; 2004 Jul; 148(1):157-64. PubMed ID: 15215806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial.
    Schwalm JD; Ahmad M; Salehian O; Eikelboom JW; Natarajan MK
    J Thromb Thrombolysis; 2010 Aug; 30(2):127-32. PubMed ID: 20157843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin and aspirin in patients with heart failure and sinus rhythm.
    Homma S; Thompson JL; Pullicino PM; Levin B; Freudenberger RS; Teerlink JR; Ammon SE; Graham S; Sacco RL; Mann DL; Mohr JP; Massie BM; Labovitz AJ; Anker SD; Lok DJ; Ponikowski P; Estol CJ; Lip GY; Di Tullio MR; Sanford AR; Mejia V; Gabriel AP; del Valle ML; Buchsbaum R;
    N Engl J Med; 2012 May; 366(20):1859-69. PubMed ID: 22551105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
    N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
    Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG;
    N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.
    Rothberg MB; Celestin C; Fiore LD; Lawler E; Cook JR
    Ann Intern Med; 2005 Aug; 143(4):241-50. PubMed ID: 16103468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
    Herlitz J; Holm J; Peterson M; Karlson BW; Haglid Evander M; Erhardt L;
    Eur Heart J; 2004 Feb; 25(3):232-9. PubMed ID: 14972424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
    Brouwer MA; van den Bergh PJ; Aengevaeren WR; Veen G; Luijten HE; Hertzberger DP; van Boven AJ; Vromans RP; Uijen GJ; Verheugt FW
    Circulation; 2002 Aug; 106(6):659-65. PubMed ID: 12163424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.